EBOS yesterday released its
annual report, detailing the
company’s 15.1% increase in net
profit to NZ$105.9 million last year
on turnover which for the first time
exceeded $6 billion (PD 26 Aug).
The report also provides
more information on last year’s
acquisition of Good Price Pharmacy
Warehouse (GPPW) (PD 27 Aug
2014), with EBOS now holding 25%
of the business after paying just
under $8 million for the stake.
CEO Patrick Davies said the deal
had paved the way for the supply
of Symbion pharmaceuticals
to all GPPW stores and added
opportunity for development of the
brand’s franchise network.The above article was sent to subscribers in Pharmacy Daily's issue from 25 Sep 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Sep 15
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.